MYL(SH:600993) Zheng Quan Zhi Xing·2025-06-30 16:34Meeting Overview - The shareholders' meeting of Mayinglong Pharmaceutical Group Co., Ltd. was held on June 30, 2025 [1] - The meeting was convened by the board of directors and chaired by Chairman Chen Ping, utilizing a combination of on-site and online voting methods [1][3] Voting Results - All resolutions presented at the meeting were approved, with significant support from shareholders [2][3] - For the first resolution, 206,034,314 A-shares voted in favor, representing 99.7154% of the votes [1] - The second resolution received 206,029,914 A-shares in favor, accounting for 99.7132% [1] - The third resolution had 206,030,114 A-shares in favor, which is 99.7133% [1] - The fourth resolution also passed with 206,034,214 A-shares in favor, representing 99.7153% [1] Legal Compliance - The meeting's procedures were confirmed to comply with legal regulations and the company's articles of association, ensuring the legitimacy of the convening and voting processes [3]